Your browser doesn't support javascript.
loading
Combination immunotherapy with interleukin-2 surface-modified tumor cell vaccine and programmed death receptor-1 blockade against renal cell carcinoma.
Zhang, Xinji; Shi, Xiaojun; Li, Jinlong; Hu, Zhiming; Gao, Jimin; Wu, Shihao; Long, Zhaolin.
Afiliação
  • Zhang X; Department of Urology, Shunde Hospital, Southern Medical University, Foshan, China.
  • Shi X; Department of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Li J; Institute of Biotherapy, School of Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou, China.
  • Hu Z; Institute of Biotherapy, School of Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou, China.
  • Gao J; Zhejiang Provincial Key Laboratory of Medical Genetics, School of Life Sciences, Wenzhou Medical University, Wenzhou, China.
  • Wu S; Department of Urology, Shunde Hospital, Southern Medical University, Foshan, China.
  • Long Z; Department of Urology, Shunde Hospital, Southern Medical University, Foshan, China.
Cancer Sci ; 110(1): 31-39, 2019 Jan.
Article em En | MEDLINE | ID: mdl-30343514
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Interleucina-2 / Vacinas Anticâncer / Receptor de Morte Celular Programada 1 / Imunoterapia / Neoplasias Renais Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Interleucina-2 / Vacinas Anticâncer / Receptor de Morte Celular Programada 1 / Imunoterapia / Neoplasias Renais Idioma: En Ano de publicação: 2019 Tipo de documento: Article